Home / Inspections / 1141302

FDA Inspection 1141302 — David Rizzieri, MD

David Rizzieri, MD — FEI 3017232419

The FDA completed an inspection of David Rizzieri, MD on April 13, 2021 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 13, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Durham, NC (United States)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources